Not many dividend stocks can boast the diversification, growth opportunities, and solid balance sheet of health-care company Johnson & Johnson (NYSE:JNJ). With products ranging from consumer goods, like Band-Aids, to cutting-edge drugs for the treatment of prostate cancer, Johnson & Johnson is an attractive stock to dividend investors. In this video, from the Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso discuss reasons to be bullish about Johnson & Johnson.

The relevant video segment can be found between 7:52 and 9:51.